Literature DB >> 24311642

The legend of cytomegalovirus and glioblastoma lives on.

Michael Weller1, Riccardo Soffietti, Michael Brada.   

Abstract

Entities:  

Keywords:  CMV; bias; glioblastoma; trial; valganciclovir

Mesh：

Substances：

Year:  2013        PMID： 24311642      PMCID： PMC3870830          DOI： 10.1093/neuonc/not204

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  2 in total

1.  Survival in patients with glioblastoma receiving valganciclovir.

Authors:  Cecilia Söderberg-Nauclér; Afsar Rahbar; Giuseppe Stragliotto
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

2.  Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Authors:  Giuseppe Stragliotto; Afsar Rahbar; Nina Wolmer Solberg; Anders Lilja; Chato Taher; Abiel Orrego; Birgitta Bjurman; Charlotte Tammik; Petra Skarman; Inti Peredo; Cecilia Söderberg-Nauclér
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396
  2 in total
  5 in total

1.  Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

Authors:  Peter Baumgarten; Martin Michaelis; Florian Rothweiler; Tatjana Starzetz; Holger F Rabenau; Annemarie Berger; Lukas Jennewein; Anne K Braczynski; Kea Franz; Volker Seifert; Joachim P Steinbach; Regina Allwinn; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

Review 2.  Cytomegalovirus and glioblastoma; controversies and opportunities.

Authors:  Sean E Lawler
Journal:  J Neurooncol       Date:  2015-02-15       Impact factor: 4.130

Review 3.  The Viral Connection to Glioblastoma.

Authors:  J Ricardo McFaline-Figueroa; Patrick Y Wen
Journal:  Curr Infect Dis Rep       Date:  2017-02       Impact factor: 3.725

Review 4.  Immunotherapeutic advancements for glioblastoma.

Authors:  Leonel Ampie; Eric C Woolf; Christopher Dardis
Journal:  Front Oncol       Date:  2015-01-29       Impact factor: 6.244

Review 5.  Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.

Authors:  Tianrui Yang; Delin Liu; Shiyuan Fang; Wenbin Ma; Yu Wang
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.